LeMaitre Vascular (LMAT) Competitors

LeMaitre Vascular (NASDAQ:LMAT) and iRhythm Technologies (NASDAQ:IRTC) are both mid-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, earnings, dividends, profitability, analyst recommendations, valuation and risk.

Do analysts recommend LMAT or IRTC?

LeMaitre Vascular presently has a consensus target price of $98.00, indicating a potential upside of 2.29%. iRhythm Technologies has a consensus target price of $157.30, indicating a potential downside of 2.96%. Given LeMaitre Vascular's higher probable upside, analysts clearly believe LeMaitre Vascular is more favorable than iRhythm Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LeMaitre Vascular	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
iRhythm Technologies	0 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	3.00

Which has stronger valuation and earnings, LMAT or IRTC?

LeMaitre Vascular has higher earnings, but lower revenue than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LeMaitre Vascular	$219.86M	9.87	$44.04M	$2.06	46.51
iRhythm Technologies	$591.84M	8.80	-$113.29M	-$2.93	-55.32

Does the media favor LMAT or IRTC?

In the previous week, LeMaitre Vascular had 9 more articles in the media than iRhythm Technologies. MarketBeat recorded 22 mentions for LeMaitre Vascular and 13 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 0.91 beat LeMaitre Vascular's score of 0.72 indicating that iRhythm Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LeMaitre Vascular	6 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
iRhythm Technologies	8 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do institutionals & insiders have more ownership in LMAT or IRTC?

84.6% of LeMaitre Vascular shares are held by institutional investors. 9.5% of LeMaitre Vascular shares are held by insiders. Comparatively, 1.1% of iRhythm Technologies shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Is LMAT or IRTC more profitable?

LeMaitre Vascular has a net margin of 20.08% compared to iRhythm Technologies' net margin of -14.06%. LeMaitre Vascular's return on equity of 13.67% beat iRhythm Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LeMaitre Vascular	20.08%	13.67%	9.14%
iRhythm Technologies	-14.06%	-90.03%	-8.52%

Which has more risk and volatility, LMAT or IRTC?

LeMaitre Vascular has a beta of 0.79, meaning that its share price is 21% less volatile than the S&P 500. Comparatively, iRhythm Technologies has a beta of 1.41, meaning that its share price is 41% more volatile than the S&P 500.

Summary

LeMaitre Vascular beats iRhythm Technologies on 11 of the 17 factors compared between the two stocks.